BioLargo, Inc.
BLGO
$0.2639
-$0.0002-0.08%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -21.77% | -7.56% | 43.76% | 39.25% | 9.64% |
| Total Depreciation and Amortization | 13.33% | 0.00% | -31.82% | 15.79% | -11.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -198.52% | -21.62% | -74.18% | 105.11% | 310.92% |
| Change in Net Operating Assets | -3,622.22% | -95.28% | 257.14% | -81.09% | 44.32% |
| Cash from Operations | -972.85% | -131.39% | 24,150.00% | 99.76% | 43.67% |
| Capital Expenditure | 89.11% | 58.52% | -491.10% | 28.78% | -159.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 89.11% | 58.52% | -491.10% | 28.78% | -159.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.33% | 40.00% | -109.09% | 558.33% | -140.00% |
| Issuance of Common Stock | -23.35% | -7.90% | 79.54% | 162.34% | -71.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -87.85% | -72.88% |
| Cash from Financing | -23.52% | -7.76% | 42.31% | 50.10% | -73.05% |
| Foreign Exchange rate Adjustments | 119.67% | -163.54% | 182.76% | -11,700.00% | 114.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -305.83% | -46.17% | 60.36% | 193.25% | -271.38% |
